As pediatric hospitals fill up with young children sickened by respiratory syncytial virus, doctors are worried that older adults will be the next wave to become seriously ill.
Lead author Dr. Naveed Janjua said the findings related to second doses for both vaccines show men between the ages of 18 and 29 are most at risk of myocarditis if they received Moderna's COVID-19 vaccine.